These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
165 related articles for article (PubMed ID: 29284258)
1. pH-Sensitive Coiled-Coil Peptide-Cross-Linked Hyaluronic Acid Nanogels: Synthesis and Targeted Intracellular Protein Delivery to CD44 Positive Cancer Cells. Ding L; Jiang Y; Zhang J; Klok HA; Zhong Z Biomacromolecules; 2018 Feb; 19(2):555-562. PubMed ID: 29284258 [TBL] [Abstract][Full Text] [Related]
2. Hyaluronic acid-shelled acid-activatable paclitaxel prodrug micelles effectively target and treat CD44-overexpressing human breast tumor xenografts in vivo. Zhong Y; Goltsche K; Cheng L; Xie F; Meng F; Deng C; Zhong Z; Haag R Biomaterials; 2016 Apr; 84():250-261. PubMed ID: 26851390 [TBL] [Abstract][Full Text] [Related]
3. Redox-Sensitive and Intrinsically Fluorescent Photoclick Hyaluronic Acid Nanogels for Traceable and Targeted Delivery of Cytochrome c to Breast Tumor in Mice. Li S; Zhang J; Deng C; Meng F; Yu L; Zhong Z ACS Appl Mater Interfaces; 2016 Aug; 8(33):21155-62. PubMed ID: 27509045 [TBL] [Abstract][Full Text] [Related]
4. EGFR and CD44 Dual-Targeted Multifunctional Hyaluronic Acid Nanogels Boost Protein Delivery to Ovarian and Breast Cancers In Vitro and In Vivo. Chen J; Ouyang J; Chen Q; Deng C; Meng F; Zhang J; Cheng R; Lan Q; Zhong Z ACS Appl Mater Interfaces; 2017 Jul; 9(28):24140-24147. PubMed ID: 28675028 [TBL] [Abstract][Full Text] [Related]
5. NIR and UV-responsive degradable hyaluronic acid nanogels for CD44-targeted and remotely triggered intracellular doxorubicin delivery. Hang C; Zou Y; Zhong Y; Zhong Z; Meng F Colloids Surf B Biointerfaces; 2017 Oct; 158():547-555. PubMed ID: 28743090 [TBL] [Abstract][Full Text] [Related]
6. CD44 Receptor Targeting and Endosomal pH-Sensitive Dual Functional Hyaluronic Acid Micelles for Intracellular Paclitaxel Delivery. Liu Y; Zhou C; Wang W; Yang J; Wang H; Hong W; Huang Y Mol Pharm; 2016 Dec; 13(12):4209-4221. PubMed ID: 27796093 [TBL] [Abstract][Full Text] [Related]
7. Hyaluronan magnetic nanoparticle for mitoxantrone delivery toward CD44-positive cancer cells. Sargazi A; Shiri F; Keikha S; Majd MH Colloids Surf B Biointerfaces; 2018 Nov; 171():150-158. PubMed ID: 30025377 [TBL] [Abstract][Full Text] [Related]
8. Hyaluronic Acid-Based pH-Sensitive Polymer-Modified Liposomes for Cell-Specific Intracellular Drug Delivery Systems. Miyazaki M; Yuba E; Hayashi H; Harada A; Kono K Bioconjug Chem; 2018 Jan; 29(1):44-55. PubMed ID: 29183110 [TBL] [Abstract][Full Text] [Related]
9. Small, Traceable, Endosome-Disrupting, and Bioresponsive Click Nanogels Fabricated via Microfluidics for CD44-Targeted Cytoplasmic Delivery of Therapeutic Proteins. Huang K; He Y; Zhu Z; Guo J; Wang G; Deng C; Zhong Z ACS Appl Mater Interfaces; 2019 Jun; 11(25):22171-22180. PubMed ID: 31190543 [TBL] [Abstract][Full Text] [Related]
10. Hyaluronic acid-coated single-walled carbon nanotubes loaded with doxorubicin for the treatment of breast cancer. Liu D; Zhang Q; Wang J; Fan L; Zhu W; Cai D Pharmazie; 2019 Feb; 74(2):83-90. PubMed ID: 30782256 [TBL] [Abstract][Full Text] [Related]
11. Targeted intracellular protein delivery based on hyaluronic acid-green tea catechin nanogels. Liang K; Ng S; Lee F; Lim J; Chung JE; Lee SS; Kurisawa M Acta Biomater; 2016 Mar; 33():142-52. PubMed ID: 26785145 [TBL] [Abstract][Full Text] [Related]
12. Dual pH-responsive multifunctional nanoparticles for targeted treatment of breast cancer by combining immunotherapy and chemotherapy. Liu Y; Qiao L; Zhang S; Wan G; Chen B; Zhou P; Zhang N; Wang Y Acta Biomater; 2018 Jan; 66():310-324. PubMed ID: 29129789 [TBL] [Abstract][Full Text] [Related]
13. Saporin-loaded CD44 and EGFR dual-targeted nanogels for potent inhibition of metastatic breast cancer in vivo. Chen J; He H; Deng C; Yin L; Zhong Z Int J Pharm; 2019 Apr; 560():57-64. PubMed ID: 30699364 [TBL] [Abstract][Full Text] [Related]
15. Reversibly crosslinked hyaluronic acid nanoparticles for active targeting and intelligent delivery of doxorubicin to drug resistant CD44+ human breast tumor xenografts. Zhong Y; Zhang J; Cheng R; Deng C; Meng F; Xie F; Zhong Z J Control Release; 2015 May; 205():144-54. PubMed ID: 25596560 [TBL] [Abstract][Full Text] [Related]
16. Hyaluronic acid-based nanogel-drug conjugates with enhanced anticancer activity designed for the targeting of CD44-positive and drug-resistant tumors. Wei X; Senanayake TH; Warren G; Vinogradov SV Bioconjug Chem; 2013 Apr; 24(4):658-68. PubMed ID: 23547842 [TBL] [Abstract][Full Text] [Related]
17. Bioresponsive and fluorescent hyaluronic acid-iodixanol nanogels for targeted X-ray computed tomography imaging and chemotherapy of breast tumors. Zhu Y; Wang X; Chen J; Zhang J; Meng F; Deng C; Cheng R; Feijen J; Zhong Z J Control Release; 2016 Dec; 244(Pt B):229-239. PubMed ID: 27568289 [TBL] [Abstract][Full Text] [Related]
18. Hyaluronic acid-nimesulide conjugates as anticancer drugs against CD44-overexpressing HT-29 colorectal cancer in vitro and in vivo. Jian YS; Chen CW; Lin CA; Yu HP; Lin HY; Liao MY; Wu SH; Lin YF; Lai PS Int J Nanomedicine; 2017; 12():2315-2333. PubMed ID: 28392690 [TBL] [Abstract][Full Text] [Related]
19. Redox-responsive hyaluronic acid nanogels for hyperthermia- assisted chemotherapy to overcome multidrug resistance. Li B; Xu Q; Li X; Zhang P; Zhao X; Wang Y Carbohydr Polym; 2019 Jan; 203():378-385. PubMed ID: 30318226 [TBL] [Abstract][Full Text] [Related]
20. Paclitaxel delivered by CD44 receptor-targeting and endosomal pH sensitive dual functionalized hyaluronic acid micelles for multidrug resistance reversion. Liu Y; Zhou C; Wei S; Yang T; Lan Y; Cao A; Yang J; Hou Y Colloids Surf B Biointerfaces; 2018 Oct; 170():330-340. PubMed ID: 29936386 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]